Drug intelligence / Profile preview

ibuprofen 2% mouthwash

Development stage
Unknown
Lead developer
Department of Periodontics
Modality
Small Molecules
Administration
Topical
01

Overview

Ibuprofen 2% mouthwash is an investigational topical formulation developed by researchers at the Islamic Azad University, Sanandaj, for the treatment of chronic periodontitis. As a nonsteroidal anti-inflammatory drug (NSAID), ibuprofen acts by inhibiting cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, which in turn reduces the synthesis of pro-inflammatory prostaglandins. In the context of periodontal disease, this formulation is used for subgingival irrigation as an adjunct to scaling and root planing (SRP) to improve clinical parameters such as probing pocket depth, clinical attachment level, and bleeding indices by localized reduction of inflammation within the periodontal pockets. The mouthwash was specifically manufactured for clinical research by the Faculty of Pharmaceutical Sciences at Islamic Azad University, Tehran.

Other names
ibuprofen mouthwash2% ibuprofen mouthwash
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on ibuprofen 2% mouthwash.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen 2% mouthwash.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call